Concepedia

Author

Jean François Ramée

Hôpital Privé Jean Mermo

Also Known As

J.F. Ramee, J.F. Ramée, Jean François Ramée

15

Publications

88

Citations

6

H-Index

21

Concepts

All Affiliations

Hôpital Privé Jean MermoHôpital Saint-AntoineHôpital Ambroise-ParéHôpital FochGERCOR (France)
JF

About

Jean François Ramée is an author at Hôpital Privé Jean Mermo specializing in medicine, cancer therapeutics, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

69

2

Health Sciences

3

3

59

3

Gastroenterology

1

1

13

4

Immunology

1

1

35

5

Nephrology

1

1

13

Jean François Ramée

×

4

Publications

69

Citations

4

H-Index

YearCitations

Bevacizumab (Bev) with or without erlotinib as maintenance therapy, following induction first-line chemotherapy plus Bev, in patients (pts) with metastatic colorectal cancer (mCRC): Efficacy and safety results of the International GERCOR DREAM phase III trial.

Christophe Tournigand, Benoît Samson, Werner Scheithauer,

Journal of Clinical Oncology

2012

35

Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer.

Jean Philippe Metges, Jean François Ramée, Jean‐Yves Douillard,

Journal of Clinical Oncology

2014

13

Maintenance therapy with bevacizumab with or without erlotinib in metastatic colorectal cancer (mCRC) according to KRAS: Results of the GERCOR DREAM phase III trial.

Christophe Tournigand, Benoist Chibaudel, Benoît Samson,

Journal of Clinical Oncology

2013

11

Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study

Benoist Chibaudel, Christophe Tournigand, Benoît Samson,

Annals of Oncology

2014

10

Page 1